Food, glorious food.

We all love to eat, but many people are unaware of the correlation between food and medicine effectiveness.

In the world of testing there’s one study which identifies this connection: a food effect study. Considering that food can change the rate of absorption and the pharmacokinetics of drugs administered orally it’s important to understand this aspect of a drugs effect, and indeed the FDA often requires this determination.

In order to be certain of the results, obtaining a full pharmacokinetic curve of concentration, dependent on time, is crucial to the success of the of study; specifically, it’s important to pay close attention to the sampling schedule during the protocol development and to devise a proper blood sampling schedule considering the possibility that food can alter the time course of plasma drug concentrations.

Whether it’s a high-protein meal, a few snacks throughout the day or a standard high-calorie breakfast, it’s essential to have a trusted partner who can help you determine the best advice to give patients.

Offering comprehensive consultancy, including the creation of sampling schemes for specific molecules and determining the overall suitability of a food effect study, plus the capability to conduct trials in their own in-house unit, QUINTA-ANALYTICA are true experts in this field and others.

Get in touch at with us to find out more about food studies and the A-Z of other pharma services Quinta offer.

Additional News

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.